- FoI Number
- 2024-534
- Subject
- HIV Treatment
- Date Received
- 22/11/2024
- Request and Response
-
- How many patients were treated in the last 6-month period with Truvada (emtricitabine / tenofovir disoproxil fumarate) or generic emtricitabine / tenofovir disoproxil fumarate for HIV treatment?
Nil
- How many patients were treated in the last 6-month period with Truvada (emtricitabine / tenofovir disoproxil fumarate) or generic emtricitabine / tenofovir disoproxil fumarate for Pre-exposure prophylaxis (PrEP)?
12
- How many packs of Truvada (emtricitabine / tenofovir disoproxil fumarate) or generic emtricitabine / tenofovir disoproxil fumarate were dispensed in latest 6-month period for HIV treatment?
Nil
- How many packs of Truvada (emtricitabine / tenofovir disoproxil fumarate) or generic emtricitabine / tenofovir disoproxil fumarate were dispensed in latest 6-month period for Pre-exposure prophylaxis (PrEP)?
31
- How many patients were treated in the last 6-month period with Descovy (tenofovir alafenamide / emtricitabine) for HIV treatment?
Nil
- How many patients were treated in the last 6-month period with Descovy (tenofovir alafenamide / emtricitabine) for Pre-exposure prophylaxis (PrEP)?
Nil
- How many packs of Descovy (tenofovir alafenamide / emtricitabine) were dispensed in latest 6-month period for HIV treatment?
Nil
- How many packs of Descovy (tenofovir alafenamide / emtricitabine) were dispensed in latest 6-month period for Pre-exposure prophylaxis (PrEP)?
Nil
